schizophrenia Archives | Be Korea-savvy
Boehringer provides update on iclepertin Phase III program in schizophrenia

Boehringer provides update on iclepertin Phase III program in schizophrenia

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints were not met.1–6 Overall, no statistically significant effects on cognition or functioning were observed in patients treated with iclepertin versus placebo at six months.1 All three trials demonstrated that iclepertin, a [...]

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)

New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000)

As a leader in neuroscience, Teva remains committed to helping address unmet needs in the treatment of schizophrenia through scientific and clinical advances that support optimal treatment options and decisions for patients and HCPs New data demonstrate switching to UZEDY at four weeks after the last dose of once-monthly RBP-7000 provided the most comparable pharmacokinetic (PK) profile based on relevant simulations, with comparable doses identified New ADVANCE survey findings highlight key patient-reported [...]

Koreans with Mental Illness: ‘Please Don’t Stigmatize Us’

Koreans with Mental Illness: ‘Please Don’t Stigmatize Us’

  SEOUL, June 9 (Korea Bizwire) – Following the Gangnam Station murder last month, the government is planning to take more serious action against schizophrenia patients, including involuntary hospitalization. However, many of those suffering from mental disorders have pleaded that their illnesses do not make them potential criminals. The ‘Experts Debate for Countermeasures against Social Hatred [...]

Korean and American Researchers Isolate Genes Triggering Mental Disorders

Korean and American Researchers Isolate Genes Triggering Mental Disorders

SEOUL, Jun. 29 (Korea Bizwire) — Korean and American researchers have found a correlation between a group of genes that are known to trigger depression, schizophrenia and bipolar diseases. A team led by professor Lee Do-Heon at the Bio-Synergy Research Center and Dr. Kim Sang-Hyun at the Stanley Medical Research Institute (SMRI) said on June [...]